These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 36790693)
21. Ginsenoside compound K inhibits the proliferation, migration and invasion of Eca109 cell via VEGF-A/Pi3k/Akt pathway. Huang J; Pan D; Liu F; Hong Y; Huang G; Huang X; Wang X; Lin Z J Cardiothorac Surg; 2022 May; 17(1):99. PubMed ID: 35505354 [TBL] [Abstract][Full Text] [Related]
22. Ginsenoside Rg3 Reduces Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor-β1 by Inactivation of AKT in HMrSV5 Peritoneal Mesothelial Cells. Yan X; Zhang W; Kong F; Li Q; Shan W; Zhang C; Han T; Che Y; Zhang Y Med Sci Monit; 2019 Sep; 25():6972-6979. PubMed ID: 31527568 [TBL] [Abstract][Full Text] [Related]
23. Ginsenoside Rg3 and sorafenib combination therapy relieves the hepatocellular carcinomaprogression through regulating the HK2-mediated glycolysis and PI3K/Akt signaling pathway. Wei Q; Ren Y; Zheng X; Yang S; Lu T; Ji H; Hua H; Shan K Bioengineered; 2022 May; 13(5):13919-13928. PubMed ID: 35719058 [TBL] [Abstract][Full Text] [Related]
24. Protective Effect of 20(R)-Ginsenoside Rg3 Against Cisplatin-Induced Renal Toxicity via PI3K/AKT and NF-[Formula: see text]B Signaling Pathways Based on the Premise of Ensuring Anticancer Effect. Zhang JJ; Zhou YD; Liu YB; Wang JQ; Li KK; Gong XJ; Lin XH; Wang YP; Wang Z; Li W Am J Chin Med; 2021; 49(7):1739-1756. PubMed ID: 34461812 [TBL] [Abstract][Full Text] [Related]
25. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer. Zhou Y; Li S; Li J; Wang D; Li Q Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819 [TBL] [Abstract][Full Text] [Related]
26. Cyanidin-3-glucoside suppresses the progression of lung adenocarcinoma by downregulating TP53I3 and inhibiting PI3K/AKT/mTOR pathway. Chen X; Zhang W; Xu X World J Surg Oncol; 2021 Aug; 19(1):232. PubMed ID: 34362378 [TBL] [Abstract][Full Text] [Related]
27. P-Y/G@NHs sensitizes non-small cell lung cancer cells to radiotherapy via blockage of the PI3K/AKT signaling pathway. Zhang L; Zhou C; Zhou Y; Zhang W; Hu X; Chen M; Hui H; Guo L; Wu C; Zhou J; Yin H Bioorg Chem; 2023 Feb; 131():106317. PubMed ID: 36525920 [TBL] [Abstract][Full Text] [Related]
28. Co-treatment with Ginsenoside 20(S)-Rg3 and Curcumin increases Radiosensitivity of MDA-MB-231 Cancer Cell Line. Changizi V; Gharekhani V; Motavaseli E Iran J Med Sci; 2021 Jul; 46(4):291-297. PubMed ID: 34305241 [TBL] [Abstract][Full Text] [Related]
29. Ginsenoside Rh2 impedes proliferation and migration and induces apoptosis by regulating NF-κB, MAPK, and PI3K/Akt/mTOR signaling pathways in osteosarcoma cells. Li C; Gao H; Feng X; Bi C; Zhang J; Yin J J Biochem Mol Toxicol; 2020 Dec; 34(12):e22597. PubMed ID: 32762018 [TBL] [Abstract][Full Text] [Related]
30. Rare Ginsenoside 20(R)-Rg3 Inhibits D-Galactose-Induced Liver and Kidney Injury by Regulating Oxidative Stress-Induced Apoptosis. Li W; Wang JQ; Zhou YD; Hou JG; Liu Y; Wang YP; Gong XJ; Lin XH; Jiang S; Wang Z Am J Chin Med; 2020; 48(5):1141-1157. PubMed ID: 32668974 [TBL] [Abstract][Full Text] [Related]
31. Ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to γ-radiation by targeting the nuclear factor-κB pathway. Wang L; Li X; Song YM; Wang B; Zhang FR; Yang R; Wang HQ; Zhang GJ Mol Med Rep; 2015 Jul; 12(1):609-14. PubMed ID: 25738799 [TBL] [Abstract][Full Text] [Related]
32. Sodium Danshensu inhibits the progression of lung cancer by regulating PI3K/Akt signaling pathway. Wang M; Tang W; Gong N; Liu P Drug Dev Res; 2022 Feb; 83(1):88-96. PubMed ID: 34196024 [TBL] [Abstract][Full Text] [Related]
33. Ginsenoside Rg3 enhances radiosensitization of hypoxic oesophageal cancer cell lines through vascular endothelial growth factor and hypoxia inducible factor 1α. Ge X; Zhen F; Yang B; Yang X; Cai J; Zhang C; Zhang S; Cao Y; Ma J; Cheng H; Sun X J Int Med Res; 2014 Jun; 42(3):628-40. PubMed ID: 24691458 [TBL] [Abstract][Full Text] [Related]
34. Apigenin inhibits cell proliferation, migration, and invasion by targeting Akt in the A549 human lung cancer cell line. Zhou Z; Tang M; Liu Y; Zhang Z; Lu R; Lu J Anticancer Drugs; 2017 Apr; 28(4):446-456. PubMed ID: 28125432 [TBL] [Abstract][Full Text] [Related]
35. Ginsenoside 3β-O-Glc-DM (C3DM) suppressed glioma tumor growth by downregulating the EGFR/PI3K/AKT/mTOR signaling pathway and modulating the tumor microenvironment. Tang M; Deng H; Zheng K; He J; Yang J; Li Y Toxicol Appl Pharmacol; 2023 Feb; 460():116378. PubMed ID: 36641037 [TBL] [Abstract][Full Text] [Related]
36. Lappaconitine sulfate induces apoptosis and G0/G1 phase cell cycle arrest by PI3K/AKT signaling pathway in human non-small cell lung cancer A549 cells. Qu D; Ma J; Song N; Hui L; Yang L; Guo Y; Sang C Acta Histochem; 2020 Jul; 122(5):151557. PubMed ID: 32622431 [TBL] [Abstract][Full Text] [Related]
37. Effect of vitamin D on malignant behavior of non-small cell lung cancer cells. Songyang Y; Song T; Shi Z; Li W; Yang S; Li D Gene; 2021 Feb; 768():145309. PubMed ID: 33197518 [TBL] [Abstract][Full Text] [Related]
38. BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway. Yang XX; Ma M; Sang MX; Zhang XY; Liu ZK; Song H; Zhu SC Oncol Rep; 2018 Feb; 39(2):667-678. PubMed ID: 29207170 [TBL] [Abstract][Full Text] [Related]
39. 20-(s)-ginsenoside Rg3 induces apoptotic cell death in human leukemic U937 and HL-60 cells through PI3K/Akt pathways. Qiu XM; Bai X; Jiang HF; He P; Wang JH Anticancer Drugs; 2014 Oct; 25(9):1072-80. PubMed ID: 25035959 [TBL] [Abstract][Full Text] [Related]
40. A SERS-Based Dual-Parameter Monitoring Nanoprobe of ROS and PI3K/Akt during Ginsenoside Rg3-Induced Cell Apoptosis. Wan J; Cheng W; Xing X; He Y; Tang P; Feng Y; Liu S; Lu X; Zhong L Biosensors (Basel); 2023 Jan; 13(2):. PubMed ID: 36831977 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]